Clinical Trials Browser

Hepatitis B × lenvatinib × Gastrointestinal × Clear all

NCT05195294 2025-03-10

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Phase 2 Not yet recruiting

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

NCT04044651 2020-01-09

Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection

Phase 2/3 Withdrawn

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular